These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37725768)

  • 1. Pediatric Rattlesnake Envenomations Treated With Crotalidae Equine Immune F(Ab') 2 Antivenom : A 3-Year Retrospective Observational Analysis.
    Seltzer JA; Winkler GA; Friedman NA; Galust H; Hardin J; Srihari P; Ontiveros S; Corbett B; Clark RF
    Pediatr Emerg Care; 2023 Oct; 39(10):776-779. PubMed ID: 37725768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Experience with F(ab')2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a single poison center during 2019.
    Wilson BZ; Bahadir A; Andrews M; Karpen J; Winkler G; Smelski G; Dudley S; Walter FG; Shirazi FM
    Toxicon; 2022 Apr; 209():10-17. PubMed ID: 35085602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms.
    Dudley S; Smelski G; Massey DJ; Maciulewicz T; Cardwell MD; Shirazi FM
    Toxicon; 2022 Jun; 212():49-54. PubMed ID: 35413335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of F(ab')
    Mascarenas DN; Fullerton L; Smolinske SC; Warrick BJ; Seifert SA
    Toxicon; 2020 Oct; 186():42-45. PubMed ID: 32763251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Crotalidae equine immune F(ab')
    Wilson BZ; Larsen J; Smelski G; Dudley S; Shirazi FM
    Clin Toxicol (Phila); 2021 Nov; 59(11):1023-1026. PubMed ID: 33703984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of both Fab and F(ab')
    Martin AM; Wang GS; Poel K
    Am J Emerg Med; 2021 Jul; 45():677.e1-677.e3. PubMed ID: 33293188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')
    Spyres MB; Padilla GK; Gerkin RD; Hoyte CO; Wolk BJ; Ruha AM;
    Clin Toxicol (Phila); 2022 Jul; 60(7):838-842. PubMed ID: 35261320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Experience with Crotalidae Immune F(ab')
    Ruha AM; Padilla-Jones A; Canning J; Spyres MB; Curry SC
    J Med Toxicol; 2022 Jan; 18(1):38-42. PubMed ID: 34665424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of Crotalidae Immune F(ab')
    Levine M; Spungen H; Pizon AF
    Ann Emerg Med; 2022 Dec; 80(6):525-527. PubMed ID: 35953386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
    Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
    Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')
    Gerardo CJ; Vissoci JR; Brown MW; Bush SP
    Clin Toxicol (Phila); 2017 Feb; 55(2):109-114. PubMed ID: 27806644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019-2021.
    Brandehoff N; Dalton A; Daugherty C; Dart RC; Monte AA;
    J Med Toxicol; 2023 Jul; 19(3):248-254. PubMed ID: 37115482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
    Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
    Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravenous equine F(ab')2: insights following clinical trials involving 1534 recipients of scorpion antivenom.
    Boyer L; Degan J; Ruha AM; Mallie J; Mangin E; Alagón A
    Toxicon; 2013 Dec; 76():386-93. PubMed ID: 23916602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators.
    Chippaux JP; Lang J; Eddine SA; Fagot P; Rage V; Peyrieux JC; Le Mener V
    Trans R Soc Trop Med Hyg; 1998; 92(6):657-62. PubMed ID: 10326114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new F(ab')
    Lasoff DR; Ruha AM; Curry SC; Koh C; Clark RF
    Am J Emerg Med; 2016 Oct; 34(10):2003-2006. PubMed ID: 27567423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe administration of Crotalidae equine immune F(ab')2 antivenom in a patient who suffered anaphylaxis from Crotalidae polyvalent immune Fab antivenom.
    Trautman WJ; Ahmed F; Barton DJ; Abesamis MG; Lynch MJ
    Am J Emerg Med; 2023 Oct; 72():221.e1-221.e3. PubMed ID: 37648591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 272 cases of rattlesnake envenomation in dogs: Demographics and treatment including safety of F(ab')2 antivenom use in 236 patients.
    Witsil AJ; Wells RJ; Woods C; Rao S
    Toxicon; 2015 Oct; 105():19-26. PubMed ID: 26341419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation.
    Offerman SR; Bush SP; Moynihan JA; Clark RF
    Pediatrics; 2002 Nov; 110(5):968-71. PubMed ID: 12415038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.